NZ750329B2 - 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases - Google Patents
5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseasesInfo
- Publication number
- NZ750329B2 NZ750329B2 NZ750329A NZ75032917A NZ750329B2 NZ 750329 B2 NZ750329 B2 NZ 750329B2 NZ 750329 A NZ750329 A NZ 750329A NZ 75032917 A NZ75032917 A NZ 75032917A NZ 750329 B2 NZ750329 B2 NZ 750329B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- pyrrolo
- dihydro
- neurodegenerative diseases
- pyridine derivatives
- treating neurological
- Prior art date
Links
Abstract
The present invention provides the compound 1-(2,4-Dimethyl-5,7- dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3- yl}ethanone or pharmaceutically acceptable salts thereof.
Claims (3)
1. A compound having the structure: , or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 having the structure:
3. The compound of claim 1, which is a pharmaceutically acceptable salt of a compound having the structure:
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NZ750329A NZ750329A (en) | 2025-01-31 |
| NZ750329B2 true NZ750329B2 (en) | 2025-05-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017035353A8 (en) | Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders | |
| HK1255269A1 (en) | Heteroaryl derivatives as parp inhibitors | |
| EP4656249A3 (en) | Pyrazolopyrimidine derivatives as kinase inhibitor | |
| TN2019000107A1 (en) | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | |
| IL311677B1 (en) | Bicyclic heterocyclyl derivatives as irak4 inhibitors | |
| EP4321513A3 (en) | Pyrrolotriazine compounds as tam inhibitors | |
| WO2016089060A3 (en) | Heterocyclic derivatives and use thereof | |
| TN2019000110A1 (en) | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | |
| WO2016085221A3 (en) | Heteroaryl amine derivative useful as protein kinase inhibitor | |
| EP4420732A3 (en) | Fused ring heteroaryl compounds and their use as trk inhibitors | |
| WO2015200680A3 (en) | Prmt5 inhibitors and uses thereof | |
| MX2017008417A (en) | Processes for preparing ask1 inhibitors. | |
| WO2016130920A3 (en) | Lrrk2 inhibitors and methods of making and using the same | |
| WO2015095337A3 (en) | PYRAZOLO[1,5-a]PYRIMIDINECARBOXAMIDE DERIVATIVES FOR TREATING COGNITIVE IMPAIRMENT | |
| GEP20257716B (en) | Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors | |
| SA519401827B1 (en) | Pyrido[3,4-D]Pyrimidine Derivative and Pharmaceutically Acceptable Salt Thereof | |
| MX2021007247A (en) | Rapamycin derivatives. | |
| HK1257555A1 (en) | Inhibitors of the tec kinase enzyme family | |
| WO2015110491A3 (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| MX2021007258A (en) | Amorphous sparsentan compositions. | |
| EP4424370A3 (en) | 7-phenoxy-n-(3-azabicyclo[3.2.1loctan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease | |
| MX394882B (en) | IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATO 3-KINASADELTA (PI3KDELTA) | |
| WO2018039077A8 (en) | Therapeutic compounds | |
| MX2020002630A (en) | IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS. | |
| PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor |